Insider Selling at VYNE Therapeutics Signals Confidence Shift Ahead of Yarrow Merger
Insider sales at VYNE Therapeutics just before a Yarrow merger vote hint at shifting executive confidence, affecting future valuation and investor strategy.
3 minutes to read